✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Vimta Labs Ltd.

VIMTALABS

Market Cap
₹2,055 Cr.
P/E
30.78

Vimta Labs Ltd.

  • Vimta Labs
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
  • TJI Pharma
FAQs on Vimta Labs Ltd. Shareprice

Vimta Labs has given better returns compared to its competitors.
Vimta Labs has grown at ~41.58% over the last 3yrs while peers have grown at a median rate of 10.28%

Yes, Vimta Labs is expensive.
Latest PE of Vimta Labs is 30.78, while 3 year average PE is 24.79.
Also latest EV/EBITDA of Vimta Labs is 16.85 while 3yr average is 11.77.

View FAQ's On Business
Growth Table
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
Balance Sheet
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
Cash Flow
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
Quarterly Results
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Vimta Labs Ltd. Financials

Balance sheet of Vimta Labs is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Vimta Labs is decreasing.
Latest net debt of Vimta Labs is -₹57.08 Crs as of Mar-25.
This is less than Mar-24 when it was -₹32.14 Crs.

The profit is oscillating.
The profit of Vimta Labs is ₹67.34 Crs for Mar 2025, ₹41.01 Crs for Mar 2024 and ₹47.3 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vimta Labs latest dividend payout ratio is 6.66% and 3yr average dividend payout ratio is 8.37%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech